Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2014, Vol. 36 ›› Issue (8): 634-637.doi: 10.3969/j.issn.1000-6621.2014.08.003

Previous Articles     Next Articles

The past, present and future of study in the chemotherapy of drug-resistant tuberculosis

XIAO He-ping, FANG Yong, FAN Lin, LIU Yi-dian   

  1. Shanghai Key Lab of Tuberculosis, Tuberculosis Center for Diagnosis and Treatment, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai  200433, China
  • Received:2014-07-08 Online:2014-08-10 Published:2014-09-07
  • Contact: XIAO He-ping E-mail:xiaoheping_sars@163.com

Abstract: The prevalence of drug-resistant tuberculosis (TB) is one of the main challenges on current TB control which seriously influences the achievement people had made in this field. Anti-TB drugs are the most effective weapons in controlling TB, however, they have been obviously not enough to deal with multidrug-resistant TB, especially extensively drug-resistant TB, TB is more likely to become the incurable disease again because of this reason. Therefore, it is urgent to develop more effective anti-TB drugs, design the chemotherapy regiment on drug-resistant TB and solve the difficulty in treating drug-resistant TB. The authors reviewed the history, focused on the present and looked ahead the future, elucidated several issues about treatment on drug-resistant TB and had expectation that readers would have a comprehensively understanding of chemotherapy for drug-resistant TB and make efforts altogether to explore the possibility of controlling the epidemic of drug-resistant TB by chemotherapy.

Key words: Tuberculosis, multidrug-resistant/drug therapy, Clinical protocols, Retrospective studies